Title:
COMBINATION THERAPY
Document Type and Number:
Japanese Patent JP2023107801
Kind Code:
A
Abstract:
To provide a combination therapy approach for treating neuroendocrine tumors (NETs) with a combination of SSTR-targeting peptide receptor radiotherapy and PARP inhibitors.SOLUTION: The foregoing problem is solved by a radiolabelled somatostatin receptor binding compound, for use in treating cancer in a subject in need thereof, wherein the radiolabelled somatostatin receptor binding compound is administered in combination, simultaneously, separately or sequentially, with a PARP inhibitor.SELECTED DRAWING: None
Inventors:
MAURIZIO F MARIANI
FRANCESCA ORLANDI
DANIELA CHICCO
VALERIA MUZIO
CARMELINA ANGOTTI
FRANCESCA ORLANDI
DANIELA CHICCO
VALERIA MUZIO
CARMELINA ANGOTTI
Application Number:
JP2023084796A
Publication Date:
August 03, 2023
Filing Date:
May 23, 2023
Export Citation:
Assignee:
ADVANCED ACCELERATOR APPLICATIONS ITALY SRL
International Classes:
A61K45/06; A61K31/496; A61K47/64; A61K51/08; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe
Shinya Mihiro
Tatsuhiko Abe
Previous Patent: Method for manufacturing cushioning elements for sports clothing
Next Patent: Radar device and transmission/reception method
Next Patent: Radar device and transmission/reception method